{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:02:16Z","timestamp":1790258536444,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Manfred Donike Institute for Doping Analysis"},{"DOI":"10.13039\/501100001962","name":"World Anti-Doping Agency","doi-asserted-by":"publisher","award":["15A17MT"],"award-info":[{"award-number":["15A17MT"]}],"id":[{"id":"10.13039\/501100001962","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Federal Ministry of the Interior of the Federal Republic of Germany"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ghir.2017.06.002","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T14:30:34Z","timestamp":1498573834000},"page":"33-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Determination of LongR3-IGF-I, R3-IGF-I, Des1-3 IGF-I and their metabolites in human plasma samples by means of LC-MS"],"prefix":"10.1016","volume":"35","author":[{"given":"Andreas","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Walpurgis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Delahaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Fichant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm","family":"Sch\u00e4nzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Thevis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2017.06.002_bb0005","unstructured":"https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/2016-09-29_-_wada_prohibited_list_2017_eng_final.pdf, WADA List of Prohibited Substances, in, 2017."},{"key":"10.1016\/j.ghir.2017.06.002_bb0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1677\/joe.0.1700013","article-title":"Insulin, growth hormone and sport","volume":"170","author":"Sonksen","year":"2001","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ghir.2017.06.002_bb0015","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/bjp.2008.99","article-title":"Growth hormone, IGF-I and insulin and their abuse in sport","volume":"154","author":"Holt","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ghir.2017.06.002_bb0020","doi-asserted-by":"crossref","first-page":"9669","DOI":"10.1007\/s00216-013-7229-y","article-title":"Insulin-like growth factor-I (IGF-I) misuse in athletes and potential methods for detection","volume":"405","author":"Guha","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ghir.2017.06.002_bb0025","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/dta.1562","article-title":"Biochemical markers of recombinant human insulin-like growth factor-I (rhIGF-I)\/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes","volume":"5","author":"Guha","year":"2013","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.ghir.2017.06.002_bb0030","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1039\/C0AN00632G","article-title":"Determination of IGF-1 and IGF-2, their degradation products and synthetic analogues in urine by LC-MS\/MS","volume":"136","author":"Thomas","year":"2011","journal-title":"Analyst"},{"key":"10.1016\/j.ghir.2017.06.002_bb0035","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/dta.1868","article-title":"Expanded test method for peptides >2kDa employing immunoaffinity purification and LC-HRMS\/MS","volume":"7","author":"Thomas","year":"2015","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.ghir.2017.06.002_bb0040","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0955-2235(95)00007-0","article-title":"In vivo actions of IGF analogues with poor affinities for IGFBPs: metabolic and growth effects in pigs of different ages and GH responsiveness","volume":"6","author":"Walton","year":"1995","journal-title":"Prog. Growth Factor Res."},{"key":"10.1016\/j.ghir.2017.06.002_bb0045","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ghir.2010.07.001","article-title":"Detection of His-tagged Long-R(3)-IGF-I in a black market product","volume":"20","author":"Kohler","year":"2010","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.ghir.2017.06.002_bb0050","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/rcm.3388","article-title":"Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography\/electrospray ionisation tandem mass spectrometry","volume":"22","author":"Bredeh\u00f6ft","year":"2008","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.ghir.2017.06.002_bb0055","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1373\/clinchem.2013.208538","article-title":"Interlaboratory agreement of insulin-like growth factor 1 concentrations measured by mass spectrometry","volume":"60","author":"Cox","year":"2014","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ghir.2017.06.002_bb0060","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1210\/jc.2010-0008","article-title":"Serum insulin-like growth factor-I and pro-collagen type III N-terminal peptide in adolescent elite athletes: implications for the detection of growth hormone abuse in sport","volume":"95","author":"Guha","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.06.002_bb0065","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/dta.1772","article-title":"The development of decision limits for the GH-2000 detection methodology using additional insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays","volume":"7","author":"Holt","year":"2015","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.ghir.2017.06.002_bb0070","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/rcm.6908","article-title":"Quantification of intact human insulin-like growth factor-I in serum by nano-ultrahigh-performance liquid chromatography\/tandem mass spectrometry","volume":"28","author":"Lopes","year":"2014","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.ghir.2017.06.002_bb0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.aca.2015.09.036","article-title":"Metabolism of human insulin after subcutaneous administration: a possible means to uncover insulin misuse","volume":"897","author":"Thomas","year":"2015","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ghir.2017.06.002_bb0080","first-page":"113","article-title":"Oral delivery of therapeutic proteins and peptides: an overview of current technologies and recommendations for bridging from approved intravenous or subcutaneous administration to novel oral regimens","volume":"66","author":"Philippart","year":"2016","journal-title":"Drug Res."},{"key":"10.1016\/j.ghir.2017.06.002_bb0085","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00726-005-0289-3","article-title":"Strategies to improve plasma half life time of peptide and protein drugs","volume":"30","author":"Werle","year":"2006","journal-title":"Amino Acids"},{"key":"10.1016\/j.ghir.2017.06.002_bb0090","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.ajpath.2010.10.007","article-title":"IGF-1 has plaque-stabilizing effects in atherosclerosis by altering vascular smooth muscle cell phenotype","volume":"178","author":"von der Thusen","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ghir.2017.06.002_bb0095","doi-asserted-by":"crossref","first-page":"10252","DOI":"10.1021\/ac302034w","article-title":"Metabolism of growth hormone releasing peptides","volume":"84","author":"Thomas","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ghir.2017.06.002_bb0100","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/bms.1200111109","article-title":"Proposal for a common nomenclature for sequence ions in mass spectra of peptides","volume":"11","author":"Roepstorff","year":"1984","journal-title":"Biomed. Mass Spectrom."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637417300540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637417300540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:50:14Z","timestamp":1761087014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637417300540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":20,"alternative-id":["S1096637417300540"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2017.06.002","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination of LongR3-IGF-I, R3-IGF-I, Des1-3 IGF-I and their metabolites in human plasma samples by means of LC-MS","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2017.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}